Apellis Pharmaceuticals, Inc.
APLS
50 insider filings · Latest: May 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Jan 21 9:17 PM | Mark Jeffrey DelongChief Business & Strat Officer | Sale | 1,334 | $19.79 | $26.4K | 81,724(D) | View → |
| Jan 20, 2026 | Jan 21 9:16 PM | Pascal DeschateletsChief Scientific Officer | Sale | 909 | $19.79 | $18.0K | 1,157,310(D) | View → |
| Jan 20, 2026 | Jan 21 9:14 PM | Cedric FrancoisDirector, Chief Executive Officer | Sale | 8,182 | $19.79 | $161.9K | 313,237(D) | View → |
| Jan 20, 2026 | Jan 21 9:12 PM | Nur NicholsonChief Technical Officer | Sale | 2,203 | $19.79 | $43.6K | 78,843(D) | View → |
| Jan 20, 2026 | Jan 21 9:10 PM | Timothy Eugene SullivanChief Financial Officer | Sale | 2,892 | $19.79 | $57.2K | 104,188(D) | View → |
| Jan 20, 2026 | Jan 21 9:08 PM | David O. WatsonGeneral Counsel | Sale | 2,475 | $19.79 | $49.0K | 96,363(D) | View → |
| Jan 20, 2026 | Jan 20 8:42 PM | Nicholson Nur | Proposed Sale | 2,203 | $19.79 | $43.6K | — | View → |
| Jan 20, 2026 | Jan 20 8:41 PM | Watson David O. | Proposed Sale | 2,475 | $19.79 | $49.0K | — | View → |
| Jan 20, 2026 | Jan 20 8:31 PM | Francois Cedric | Proposed Sale | 8,182 | $19.79 | $161.9K | — | View → |
| Jan 20, 2026 | Jan 20 8:26 PM | DeLong Mark Jeffrey | Proposed Sale | 1,334 | $19.79 | $26.4K | — | View → |
| Jan 20, 2026 | Jan 20 8:26 PM | Deschatelets Pascal | Proposed Sale | 909 | $19.79 | $18.0K | — | View → |
| Jan 20, 2026 | Jan 20 8:19 PM | Baumal Caroline | Proposed Sale | 1,882 | $19.79 | $37.3K | — | View → |
| Jan 20, 2026 | Jan 20 8:10 PM | Sullivan Timothy Eugene | Proposed Sale | 2,892 | $19.79 | $57.2K | — | View → |
| Jan 20, 2026 | Jan 20 8:10 PM | Chopas James George | Proposed Sale | 726 | $19.79 | $14.4K | — | View → |
| Jan 13, 2026 | Jan 13 9:12 PM | Nicholson Nur | Proposed Sale | 2,618 | $22.19 | $58.1K | — | View → |
| Jan 13, 2026 | Jan 13 8:58 PM | Chopas James George | Proposed Sale | 873 | $22.19 | $19.4K | — | View → |
| Jan 13, 2026 | Jan 13 8:55 PM | Watson David O. | Proposed Sale | 5,780 | $22.19 | $128.2K | — | View → |
| Jan 13, 2026 | Jan 13 8:53 PM | DeLong Mark Jeffrey | Proposed Sale | 1,780 | $22.19 | $39.5K | — | View → |
| Jan 13, 2026 | Jan 13 8:48 PM | Deschatelets Pascal | Proposed Sale | 2,277 | $22.19 | $50.5K | — | View → |
| Jan 13, 2026 | Jan 13 8:45 PM | Francois Cedric | Proposed Sale | 10,186 | $22.19 | $226.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 14 11:37 PM | Sinclair A. DunlopDirector | Disposition | 102,826 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:34 PM | James George ChopasVP/Chief Accounting Officer | Disposition | 81,053 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:34 PM | Mikael DolstenDirector | Disposition | 24,135 | $20.96 | 0(D) | View → |
| May 14, 2026 | May 14 11:32 PM | Leslie MeltzerChief Research and Development | Disposition | 92,592 | $27.93 | 0(D) | View → |
| May 14, 2026 | May 14 11:31 PM | Paul R. FonteyneDirector | Disposition | 112,726 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:30 PM | Timothy Eugene SullivanChief Financial Officer | Disposition | 677,390 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:29 PM | Alec MachielsDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:27 PM | Pascal DeschateletsChief Scientific Officer | Disposition | 588,996 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:26 PM | Gerald ChanDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:25 PM | Nur NicholsonChief Technical Officer | Disposition | 357,594 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:24 PM | Keli WalbertDirector | Disposition | 30,072 | $33.00 | 0(D) | View → |
| May 14, 2026 | May 14 11:23 PM | Mark Jeffrey DelongChief Business & Strat Officer | Disposition | 235,736 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:22 PM | Stephanie Monaghan O'BrienDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:20 PM | Kelley BoucherChief People Officer | Disposition | 146,138 | $28.17 | 0(D) | View → |
| May 14, 2026 | May 14 11:19 PM | Craig A WheelerDirector | Disposition | 42,879 | $25.12 | 0(D) | View → |
| May 14, 2026 | May 14 11:19 PM | David O. WatsonGeneral Counsel | Disposition | 302,965 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:17 PM | Cedric FrancoisDirector, Chief Executive Officer | Disposition | 1,697,706 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:16 PM | Caroline BaumalChief Medical Officer | Disposition | 168,500 | $66.30 | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:06 PM | Mikael DolstenDirector | Grant/Award | 24,135 | $20.96 | 24,135(D) | View → |
| Feb 3, 2026 | Feb 5 9:14 PM | Cedric FrancoisDirector, Chief Executive Officer | Option Exercise | 8,840 | $3.76 | 0(D) | View → |